99 Episodo

  1. CSF proteomics in glioma

    Publicado: 21/3/2025
  2. Vorasidenib in IDH mutant glioma

    Publicado: 8/3/2025
  3. KL-50 in post TMZ MMR-deficient GBM

    Publicado: 22/2/2025
  4. Measurable disease per FET-PET vs MRI in GBM

    Publicado: 8/2/2025
  5. Pre-radiation chemotherapy in GBM

    Publicado: 20/1/2025
  6. cIMPACT-NOW Update 8: grading of meningiomas

    Publicado: 13/12/2024
  7. Residual tumor volume and survival after CCNU/TMZ in GBM

    Publicado: 24/11/2024
  8. Alterations in RNA splicing between meningioma DNA methylation groups

    Publicado: 8/11/2024
  9. The immune landscape of IDH mutant and IDHwt glioma

    Publicado: 25/10/2024
  10. Equity-driven applications of AI in neuro-oncology

    Publicado: 9/10/2024
  11. IDH mutant glioma across age groups

    Publicado: 20/9/2024
  12. Contemporary molecular prognostic signatures in glioma

    Publicado: 30/8/2024
  13. FDG PET in PCNSL

    Publicado: 9/8/2024
  14. TMZ and MGMT in elderly GBM patients

    Publicado: 12/7/2024
  15. IDH mutant glioma and IDH inhibitors

    Publicado: 5/7/2024
  16. Leptomeningeal disease, a SNO and ASCO review

    Publicado: 28/6/2024
  17. Cancer stems cell in GBM

    Publicado: 21/6/2024
  18. Drug delivery across the blood-brain barrier

    Publicado: 13/6/2024
  19. Gliomatosis cerebri in children

    Publicado: 24/5/2024
  20. Immunotherapy drives mesenchymal shift in GBM

    Publicado: 17/5/2024

1 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site